18F-Deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis

Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.

Ryūko Kubota, Satoshi Yamada, Keiichi Kubota et al. · PubMed · 1992 · 1.2K citations · Full text

Medicine, Nuclear Medicine, Oncology +13

Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.

Hans C. Steinert, M. Häuser, F Allemann et al. · Radiology · 1997 · 377 citations

Medicine, Nuclear Medicine, Oncology +17

What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?

Lars Ekberg, Ola Holmberg, Lena Wittgren et al. · Radiotherapy and Oncology · 1998 · 267 citations

Medicine, Oncology, Radiation Oncology +16

Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung Cancer

Johan Vansteenkiste, Sigrid Stroobants, Paul R. De Leyn et al. · CHEST Journal · 1997 · 196 citations

Medicine, Nuclear Medicine, Oncology +14

The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1Presented at the 13th Asia Pacific Cancer Conference, Penang, Malaysia, November 17–20, 1996 and also presented at the Royal Australasian College of Radiologists 47th Annual General and Scientific Meeting, Perth, Western Australia, October 5–9th, 1996. Accepted for presentation at the American Radium Society 79th Annual Meeting, New York, N.Y., April 30–May 4, 1997.1

John D Kiffer, Salvatore U. Berlangieri, Andrew M. Scott et al. · Lung Cancer · 1998 · 189 citations

Medicine, Oncology, Radiology +17